Drug Name: Agamree
Active Ingredient: vamorolone
Indication: To treat Duchenne muscular dystrophy
Approval Date: 10/26/2023
Company: Santhera Pharmaceuticals (USA), Inc
More: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215239s000lbl.pdf